Infosys (INFYN) AI Stock Analysis
Infosys
(BMV:INFYN)
No summary available
Infosys (INFYN) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- MXN 50.93B
- Dividend Yield
- 4.01%
- Average Volume (3M)
- 55
- Price to Earnings (P/E)
- 20.9
- Beta (1Y)
- -0.02
- Revenue Growth
- -11.65%
- EPS Growth
- -7.38%
- Country
- Mexico
- Employees
- 328,594
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Information Technology Services
Infosys Business Overview & Revenue Model
Company Description
Infosys Limited, through its global network of subsidiaries, delivers an extensive portfolio of consulting, technology, outsourcing, and next-generation digital services spanning North America, Europe, India, and other international markets. The comp...
Infosys Earnings Call Summary
The call was cautiously positive. Current revenue growth was below expectations and guidance was reduced to 1%-2%, with macro uncertainty, softer volumes, pricing pressure, weak high-tech and retail demand, and second-half margin headwinds. However, these challenges were outweighed by 29% sequential AI revenue growth, AI revenue reaching 10.5% of total revenue, $5.2 billion of large deal wins with 62% net new, an $8.8 billion H1 large-deal book up 28% year-on-year, strong free cash flow, stable margins, and management's confidence in future growth from AI adoption and mega-deal conversion.
Q2-2027 Updates
Positive Updates
Negative Updates
Company Guidance
Infosys revised its FY 2027 revenue growth guidance to 1%-2% year-on-year in constant currency terms, with the lower end assuming further deterioration in macro and the upper end assuming improvements; operating margin guidance remains 20%-22%, effective tax rates for the year are expected to be in the range of 29%-30%, and the company’s target is approximately 20,000 freshers for FY 2027. H2 margins will be impacted by compensation hikes, softer revenue seasonality, continued sharing of AI-driven productivity benefits, and ramp-up of large deals, partly offset by initiatives under Project Maximus. The $2 billion-plus seven-year mega deal is expected to contribute over 1% growth for the company in FY 2028.
Infosys Risk Analysis
Infosys disclosed 14 risk factors in its most recent earnings report. Infosys reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksInfosys Peers Comparison
Overall Rating
ACN84Outperform
G79Outperform
IBM79Outperform
CTSH77Outperform
WIT72Outperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ACN | 84Outperform | $152.63B | 18.90 | 26.77% | 2.56% | 6.47% | 11.19% |
| G | 79Outperform | $6.63B | 11.65 | 22.91% | 1.85% | 6.89% | 11.22% |
| IBM | 79Outperform | $243.66B | 21.66 | 32.95% | 2.61% | 6.83% | 39.80% |
| CTSH | 77Outperform | $29.11B | 11.86 | 17.36% | 2.00% | 4.96% | 27.16% |
| WIT | 72Outperform | $20.64B | 15.55 | 15.94% | 4.02% | 0.38% | -8.33% |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MX:INFYN | Infosys | 232.00 | -67.90 | -22.64% | |
| ACN | Accenture Plc | 258.24 | 18.16 | 7.56% | |
| CTSH | Cognizant Technology Solutions | 65.11 | -6.02 | -8.46% | |
| G | Genpact | 39.62 | 2.25 | 6.01% | |
| IBM | International Business Machines Corporation | 257.81 | -39.20 | -13.20% | |
| WIT | Wipro Limited | 2.16 | -0.37 | -14.49% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.